CD8A and metabolic dysfunction-associated steatohepatitis: As a larger number of CD69+ CD8+ Trm cells were observed in the liver of patients with advanced NASH, attempts to manipulate their number and/or function may serve as a potential therapeutic option for NASH in the future.